Cargando…
Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
BACKGROUND: p53 is a tumor suppressor and key regulator of glycolysis in cancer cells, however highly mutated in tumors. In ovarian cancer, studies concerning p53 mutations focus on the DNA binding domain since the majority of hotspot mutations affects this region. Yet, mutations in other regions su...
Autores principales: | Antoun, Stephanie, Atallah, David, Tahtouh, Roula, Alaaeddine, Nada, Moubarak, Malak, Khaddage, Abir, Ayoub, Eliane Nasr, Chahine, George, Hilal, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791177/ https://www.ncbi.nlm.nih.gov/pubmed/29422776 http://dx.doi.org/10.1186/s12935-018-0514-2 |
Ejemplares similares
-
Glucose restriction combined with chemotherapy decreases telomere length and cancer antigen-125 secretion in ovarian carcinoma
por: Antoun, Stephanie, et al.
Publicado: (2020) -
HSP27 modulates tumoural immune evasion by enhancing STAT3-mediated upregulation of PD-L1 and NLRC5 in ovarian cancer
por: Fezza, Maha, et al.
Publicado: (2023) -
Microarray analysis of breast cancer gene expression profiling in response to 2-deoxyglucose, metformin, and glucose starvation
por: Aoun, Rita, et al.
Publicado: (2022) -
Radiology management of a ‘breast unit’ during COVID-19 pandemic: a single institution experience
por: Salem, Christine, et al.
Publicado: (2020) -
Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study
por: Tahtouh, Roula, et al.
Publicado: (2015)